长风药业（02652.HK）今日盘中大跌5.45%，引发市场关注。该公司刚于10月8日在港交所主板挂牌上市，上市首日股价大涨161.02%，收于38.50港元。
分析人士认为，今日的下跌可能是上市首日暴涨后的正常调整。长风药业上市时发行价为14.75港元，募集资金净额约5.25亿港元。公司计划将募集资金用于国内外吸入制剂候选产品的研发、临床开发，以及生产设施扩张等方面。
长风药业专注于呼吸系统吸入制剂的研发，产品线覆盖哮喘、慢性阻塞性肺病及过敏性鼻炎等高需求领域。尽管今日股价回调，但投资者仍普遍看好公司的长期发展前景。市场将继续关注公司后续的研发进展及业绩表现。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.